Stockreport

US$16.33: That's What Analysts Think Revance Therapeutics, Inc. (NASDAQ:RVNC) Is Worth After Its Latest Results [Yahoo! Finance]

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF Revance Therapeutics beat expectations with revenues of US$234m arriving 3.4% ahead of forecasts. The company also reported a statutory loss of US$3.83, 3.7% smaller tha [Read more]